CD163 and colorectal carcinoma: To validate whether NOS2 and CD163 were markers, able to separate between distinct populations of macrophages, specimens of 10 CRC patients were randomly selected and the distribution of NOS2 and CD163 was analyzed by double immunoflourescent staining followed by confocal microscopy.